Metraipolis › archive › dc_0e1820cae6fa

Efficacy and safety of AAV RPGR gene therapy in X-linked retinitis pigmentosa: a systematic review and meta-analysis — Europe PMC PMID:42576225

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42576225
DOI
10.1186/s12967-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-10-16T22:13:22.996Z
SHA-256 of the archived text
dee9a802d5758186c72a3b239bbe84b6ffbff83904e5ad12d60dd4e8f856f856
Stable URL of this page
https://metraipolis.com/documento/dc_0e1820cae6fa

How to cite

Efficacy and safety of AAV RPGR gene therapy in X-linked retinitis pigmentosa: a systematic review and meta-analysis — Europe PMC PMID:42576225 — Europe PMC (en), https://europepmc.org/article/MED/42576225 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0e1820cae6fa (Metraipolis archive dc_0e1820cae6fa, sha256 dee9a802d5758186c72a3b239bbe84b6ffbff83904e5ad12d60dd4e8f856f856)
BibTeX
@misc{dc0e1820cae6fa,
  title = {Efficacy and safety of AAV RPGR gene therapy in X-linked retinitis pigmentosa: a systematic review and meta-analysis — Europe PMC PMID:42576225},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42576225},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0e1820cae6fa; sha256 dee9a802d5758186c72a3b239bbe84b6ffbff83904e5ad12d60dd4e8f856f856},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42576225. Agents can read the archived copy with the MCP tool read_document.